MRVI – Maravai Lifesciences Hldgs-A
Investors holding2
Combined shares1,914,419
Combined reported value$14.7M
MRVI chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| FPA (First Pacific Advisors) | 0.08 | 884,883 | $6.8M | Q3 2026 | |
| Paul Tudor Jones narrow view | 0.04 | Reduced 44.3% | 1,029,536 | $7.9M | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Reduced 44.3% | 1,029,536 | 0.03 |
| Q2 2026 | Paul Tudor Jones narrow view | Added 365.9% | 1,849,079 | 0.04 |
| Q1 2026 | Paul Tudor Jones narrow view | New | 396,915 | 0.01 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q2 2026 | Paul Tudor Jones narrow view | Added 365.9% | 1,849,079 | 0.04 |
| Q1 2026 | Paul Tudor Jones narrow view | New | 396,915 | 0.01 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Reduced 44.3% | 1,029,536 | 0.03 |
History
2 peakQ3 2026: 2 tracked investors
20202026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| FPA (First Pacific Advisors) | 884.9K | 884.9K | 884.9K | 884.9K | 884.9K | 741.3K | – | – |
| Paul Tudor Jones | 1.03M | 1.85M | 396.9K | – | – | – | – | – |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).